Forte Biosciences, Inc. (FBRX)
76.94
+0.02
(+0.03%)
USD |
NASDAQ |
Aug 24, 16:00
76.94
0.00 (0.00%)
After-Hours: 20:00
Forte Biosciences 1 Year Total Returns (Daily) : 592.3% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 592.3% |
| August 20, 2026 | 553.8% |
| August 19, 2026 | 554.5% |
| August 18, 2026 | 545.5% |
| August 17, 2026 | 564.6% |
| August 14, 2026 | 610.1% |
| August 13, 2026 | 627.2% |
| August 12, 2026 | 613.6% |
| August 11, 2026 | 631.4% |
| August 10, 2026 | 655.0% |
| August 07, 2026 | 645.5% |
| August 06, 2026 | 626.2% |
| August 05, 2026 | 689.8% |
| August 04, 2026 | 682.0% |
| August 03, 2026 | 697.2% |
| July 31, 2026 | 667.5% |
| July 30, 2026 | 655.8% |
| July 29, 2026 | 617.9% |
| July 28, 2026 | 559.1% |
| July 27, 2026 | 559.5% |
| July 24, 2026 | 409.6% |
| July 23, 2026 | 461.1% |
| July 22, 2026 | 443.0% |
| July 21, 2026 | 401.8% |
| July 20, 2026 | 366.5% |
| Date | Value |
|---|---|
| July 17, 2026 | 390.6% |
| July 16, 2026 | 364.8% |
| July 15, 2026 | 367.2% |
| July 14, 2026 | 339.2% |
| July 13, 2026 | 318.2% |
| July 10, 2026 | 283.4% |
| July 09, 2026 | 194.1% |
| July 08, 2026 | 64.90% |
| July 07, 2026 | 75.89% |
| July 06, 2026 | 49.41% |
| July 02, 2026 | 51.16% |
| July 01, 2026 | 71.38% |
| June 30, 2026 | 64.35% |
| June 29, 2026 | 74.04% |
| June 26, 2026 | 84.31% |
| June 25, 2026 | 76.68% |
| June 24, 2026 | 30.84% |
| June 23, 2026 | 42.24% |
| June 22, 2026 | 24.69% |
| June 18, 2026 | 43.43% |
| June 17, 2026 | 42.08% |
| June 16, 2026 | 26.10% |
| June 15, 2026 | 49.36% |
| June 12, 2026 | 40.03% |
| June 11, 2026 | 38.04% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| argenx SE | 56.66% |
| ACADIA Pharmaceuticals, Inc. | 19.02% |
| Alnylam Pharmaceuticals, Inc. | -49.48% |
| Anika Therapeutics, Inc. | 140.7% |
| Savara, Inc. | 83.28% |